Newsfiscal.ai
Guggenheim Adjusts Eloxx Pharmaceuticals Price Target
· Published
Article summary
Guggenheim has revised its price target for Eloxx Pharmaceuticals, Inc. shares, lowering the target from $43.00 to $40.00.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…